Bausch Health Companies Inc (BHC)
6.77
-0.30
(-4.24%)
USD |
NYSE |
May 17, 16:00
6.76
-0.01
(-0.15%)
Pre-Market: 20:00
Bausch Health Total Assets (Quarterly): 26.91B for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 26.91B |
December 31, 2023 | 27.35B |
September 30, 2023 | 27.06B |
June 30, 2023 | 25.50B |
March 31, 2023 | 25.44B |
December 31, 2022 | 25.69B |
September 30, 2022 | 26.30B |
June 30, 2022 | 28.17B |
March 31, 2022 | 29.09B |
December 31, 2021 | 29.20B |
September 30, 2021 | 29.25B |
June 30, 2021 | 30.04B |
March 31, 2021 | 30.20B |
December 31, 2020 | 31.20B |
September 30, 2020 | 31.56B |
June 30, 2020 | 31.40B |
March 31, 2020 | 31.86B |
December 31, 2019 | 33.86B |
September 30, 2019 | 31.67B |
June 30, 2019 | 32.35B |
March 31, 2019 | 32.55B |
December 31, 2018 | 32.49B |
September 30, 2018 | 33.78B |
June 30, 2018 | 34.45B |
March 31, 2018 | 35.80B |
Date | Value |
---|---|
December 31, 2017 | 37.50B |
September 30, 2017 | 39.97B |
June 30, 2017 | 41.73B |
March 31, 2017 | 42.33B |
December 31, 2016 | 43.53B |
September 30, 2016 | 45.76B |
June 30, 2016 | 47.66B |
March 31, 2016 | 49.02B |
December 31, 2015 | 48.96B |
September 30, 2015 | 48.45B |
June 30, 2015 | 48.34B |
March 31, 2015 | 38.57B |
December 31, 2014 | 26.30B |
September 30, 2014 | 27.06B |
June 30, 2014 | 27.90B |
March 31, 2014 | 27.99B |
December 31, 2013 | 27.97B |
September 30, 2013 | 28.20B |
June 30, 2013 | 19.78B |
March 31, 2013 | 17.49B |
December 31, 2012 | 17.95B |
September 30, 2012 | 14.15B |
June 30, 2012 | 14.02B |
March 31, 2012 | 13.62B |
December 31, 2011 | 13.11B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.44B
Minimum
Mar 2023
33.86B
Maximum
Dec 2019
29.21B
Average
29.23B
Median
Total Assets (Quarterly) Benchmarks
Acasti Pharma Inc | 76.18M |
Aurinia Pharmaceuticals Inc | 548.06M |
Edesa Biotech Inc | 6.475M |
Lexaria Bioscience Corp | 6.352M |
Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 27.09B |
Shareholders Equity (Quarterly) | -1.115B |
Debt to Equity Ratio | -19.80 |
Current Ratio | 1.225 |
Net Debt Paydown Yield | -6.72% |